Forsøgne III og V havde yderligere primære end- points i uge 52 med forsinket sygdomsprogression (bestemt ud fra røntgenresultater).
RA studies III and V had an additional primary endpoint at 52 weeks of retardation of disease progression (as detected by X-ray results).